Acadia Pharmaceuticals | ACAD - 销售成本

股票价格

20.69

每天变化

-0.03 -0.14%

每月一次

-13.76%

每年

20.43%

Q1 预测

19.99

金融业

USD

USD 1.56B

现金及等价物

USD 819.69M

USD 26.23M

USD 1.06B

USD 277.11M

USD 54.81M

USD 17.39M

USD 35.76M

653

EPS每股收益

USD 1.6

股本和储备

USD 917.27M

USD 257.76M

债务利息支出

USD 0

USD 8.25M

USD 0

USD 3.33B

USD 273.57M

USD 266.6M

USD 17.39M

普通股股本

USD 169.18M

11.61

USD 26.32M

USD 284M

销售和管理费用

USD 146.73M

USD 34.67M

贸易债权人

USD 10.9M

应收帐款人

USD 148.23M

	销售成本	更改		日
Acadia Pharmaceuticals	USD 26.22M		4.58M	2025-12
ALKERMES	USD 46.21M		5.38M	2025-12
Alnylam Pharmaceuticals	USD 267.72M		67.57M	2025-12
Biogen	USD 810.1M		205.1M	2025-09
BioMarin Pharmaceutical	USD 161.56M		16.62M	2025-12
Bristol-Myers Squibb	USD 4.92B		657M	2025-12
Cara Therapeutics	USD 0		0	2025-03
Corcept Therapeutics	USD 2.54M		2.05M	2025-12
Cytokinetics	USD 99.23M		13.32M	2025-09
Eisai	JPY 51.08B		5.56B	2025-12
Eli Lilly	USD 3.37B		363.7M	2025-12
Incyte	USD 121.18M		22.18M	2025-12
J&J	USD 7.97B		689M	2025-12
Moderna	USD 452M		245M	2025-12
Neurocrine Biosciences	USD 17.6M		246.4M	2025-12
Pfizer	USD 6.29B		2.12B	2025-12
Prothena	USD 28.94M		11.58M	2025-09
PTC Therapeutics	USD 16.3M		7.02M	2025-12
Sarepta Therapeutics	USD 399.38M		247.93M	2025-12
Ultragenyx Pharmaceutical	USD 29M		1.01M	2025-12
Vanda Pharmaceuticals	USD 198.77M		151.12M	2024-12
Vertex Pharmaceuticals	USD 466M		51.2M	2025-12